Assessing the costs and cost-effectiveness of ICare internet-based interventions (protocol) by Beecham, Jennifer et al.
Contents lists available at ScienceDirect
Internet Interventions
journal homepage: www.elsevier.com/locate/invent
Assessing the costs and cost-effectiveness of ICare internet-based
interventions (protocol)
Jennifer Beechama,b,⁎, Eva-Maria Bonina, Dennis Görlichc, Rosa Bañosd,e, Ina Beintnerf,
Claudia Buntrockg, Felix Bolinskih,i, Cristina Botellae,j, David Daniel Ebertg, Rocio Herreroj,
Rachel Pottertonk, Heleen Riperh,i, Ulrike Schmidtk, Karin Waldherrl, Kiona Weiselg,
Anna-Carlotta Zarskig,m, Michael Zeilern, Corinna Jacobif
a Personal Social Services Research Unit, London School of Economics and Political Science, Houghton Street, London WC2A 2AE, UK
b Personal Social Services Research Unit, University of Kent, Canterbury, UK
cWestfälische Wilhelms-Universität Münster, Institut für Biometrie und Klinische Forschung, Schmedingstraße 56, Münster, Germany
dUniversidad de Valencia, Spain
e CIBERObn, Instituto Salud Carlos III, Spain
f TechnischeUniversität Dresden, School of Science, Faculty of Psychology, Chair ofClinical Psychology and E-Mental-Health, 01062 Dresden, Germany
g Friedrich-Alexander Universität Erlangen-Nürnberg, Germany
hDepartment of Clinical, Neuro and Developmental Psychology, Vrije Universiteit Amsterdam, The Netherlands
i Amsterdam Public Health Research Institute, Amsterdam, The Netherlands
j Jaume I University, Castellon, Spain
k King's College London, Institute of Psychiatry, Psychology and Neuroscience, Box P059, De Crespigny Park, London SE5 8AF, UK
l FernFH Distance Learning University of Applied Sciences, Zulingergasse 4, Wiener Neustadt, Austria
m Leuphana University, Innovation Incubator, Division Health Trainings Online, Lüneburg, Germany
nMedical University of Vienna, Department for Child and Adolescent Psychiatry, Waehringer Guertel 18-20, Vienna, Austria








A B S T R A C T
Background: Mental health problems are common and place a burden on the individual as well as on societal
resources. Despite the existence of evidence-based treatments, access to treatment is often prevented or delayed
due to insufficient health care resources. Effective internet-based self-help interventions have the potential to
reduce the risk for mental health problems, to successfully bridge waiting time for face-to-face treatment and to
address inequities in access. However, little is known about the cost-effectiveness of such interventions. This
paper describes the study protocol for the economic evaluation of the studies that form the ICare programme of
internet-based interventions for the prevention and treatment of a range of mental health problems.
Methods: An overarching work package within the ICare programme was developed to assess the cost-effec-
tiveness of the internet-based interventions alongside the clinical trials. There are two underlying tasks in the
ICare economic evaluation. First, to develop schedules that generate equivalent and comparable information on
use of services and supports across seven countries taking part in clinical trials of different interventions and
second, to estimate unit costs for each service and support used. From these data the cost per person will be
estimated by multiplying each participant's use of each service by the unit cost for that service. Additionally,
productivity losses will be estimated. This individual level of cost data matches the level of outcome data used in
the clinical trials. Following the analyses of service use and costs data, joint analysis of costs and outcomes will
be undertaken to provide findings on the relative cost-effectiveness of the interventions, taking both a public
sector and a societal perspective. These analyses use a well-established framework, the Production of Welfare
approach, and standard methods and techniques underpinned by economic theory.
Discussion/conclusion: Existing research tends to support the effectiveness of internet-based interventions, but
there is little information on their cost-effectiveness compared to ‘treatment as usual’. The economic evaluation
of ICare interventions will add considerably to this evidence base.
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1. Introduction
The ICare programme is both new and wide ranging, aiming to
implement a common technology platform to deliver mental health
care across different EU countries. It has the potential to increase the
availability of internet-based interventions, and the accompanying
evaluations will provide an important addition to the evidence base on
how well this delivery mode works and whether the interventions are
cost-effective, and under what conditions. This paper describes the
economic evaluations undertaken alongside the clinical trials that form
an important part of ICare activities.
Economic evaluation provides a means of assessing the costs of an
intervention and analysing costs and effectiveness data together to es-
tablish whether one intervention is cost-effective relative to its com-
parator(s). The discipline of economics is predicated on the fact that
there are never enough resources to meet all needs and wants. The
current financial situation for health care suggests that budgets are
becoming even tighter (OECD/EU, 2016). Within constrained health
care budgets decision-makers must make choices about the best way of
spending their limited resources to improve population health out-
comes. Commissioners and providers must take into account a range of
information as they make these decisions; among others local circum-
stances, clinical preferences, residents' needs, and historical spend. By
applying the discipline of economics to the topic of health and health
care, findings from economic evaluations can further inform these de-
cisions.
There are many reasons why internet-based interventions may be
helpful in the context of a comprehensive (mental) health care system.
One review found that cost was a key reason for developing such ser-
vices (Griffiths et al., 2006). Some implementers were interested in
reducing treatment costs to users of health care. This is particularly
important in health care systems where supporting people who live in
rural areas, or where there are low levels of provision, are key issues.
Long travel distances, inconvenient appointment times for workers or
those with family commitments can impose user costs and be strong
barriers to accessing treatment – in addition to direct monetary costs
associated with accessing health care in systems where it is not free at
the point of demand. Where implementers took a health service per-
spective, key issues were found to be around treating more people with
the same resources (for example, increasing the number of people a
therapist could treat) and in ensuring speedier treatment. Reaching a
wider population with treatments, improving access to treatments, re-
ducing health inequalities and promoting a shift to interventions that
may prevent problems developing or prevent problems from getting
worse, are important aspects of European health care policy (European
Commission, 2012).
1.1. What we know
Other papers in this Special Issue point to a growing body of evi-
dence on the effectiveness of internet based interventions. However,
little is known about their associated costs or cost-effectiveness. Four
recent reviews identify cost-effectiveness evaluations occurring along-
side randomised trials, Hedman et al. (2012), Arnberg et al. (2014),
Donker et al. (2015) and Paganini et al. (2018). Tate et al. (2009) also
reviewed literature on the cost-effectiveness of internet interventions
but used wider methods criteria for their search. Of the eight studies
they identified (published 1995–2008) two did not use a monetary
valuation, and four were cost savings analyses or return on investment
studies. Only two reported incremental cost-effectiveness findings
(McConnon et al., 2007; Mihalopoulos et al., 2005).
Two reviews focused on interventions for mental health (Arnberg
et al., 2014; Donker et al., 2015). Literature searches up to March 2013
revealed five cost-effectiveness studies of internet-based interventions
for mood and anxiety disorders (139 papers screened), of which three
were excluded due to a high risk of bias (Arnberg et al., 2014). The
remaining two papers were rated as having a moderate risk of bias
(Hedman et al., 2011; Hollinghurst et al., 2010). Overall the authors
rated the quality of the evidence on cost-effectiveness as low to very
low.
Donker et al. (2015) found 16 economic evaluations occurring
alongside randomised controlled trials (RCTs) of internet interventions
for any mental health disorders (236 papers screened). They included
studies of interventions for depression (4 studies), smoking (3), social
phobia (3 studies on two trials), harmful alcohol use (2), panic disorder
(1), health anxiety (1), anxiety (1), and substance abuse (1). Given the
dispersed conditions and the different types of comparison groups, the
analysis was mainly descriptive but the authors suggest that overall,
guided internet interventions for mental health appear to be more cost-
effective than the comparator. However, unguided internet interven-
tions were found not to be more cost-effective than their comparator.
The perspective taken (social, health care providers and third-party
payers) did not appear to be related to decisions around cost-effec-
tiveness. Based on the ‘Drummond Checklist’ (Drummond et al., 1996),
the quality of the economic evaluations was found to be variable but 10
studies were considered of good quality as they adhered to at least 75%
of the guideline criteria.
Most of the papers reviewed by Donker et al. (2015) evaluated an
internet-based cognitive behavioural therapy (ICBT) so there is an
overlap of six studies with the earlier review by Hedman et al. (2012)
which only focussed on ICBT interventions. Hedman et al. (2012)
identified two further papers of ICBT for irritable bowel syndrome.
Most recently, Paganini et al. (2018) identified seven economic
evaluations of internet- and mobile-based interventions for major de-
pression, four for less severe depression, and one preventative inter-
vention. Of these, six interventions were considered cost-effective, with
cost-utility ratios ranging from €3088-€22,609. The authors note that
all of these interventions were guided, supporting earlier evidence that
adherence to web-based interventions is positively linked to increased
interaction with counsellors and that other 'persuasive technology ele-
ments' increase adherence (Kelders et al., 2012), and positive associa-
tion between the amount of therapist input and improvement in out-
come (Palmqvist et al., 2007).
An individual-level meta-analysis of guided internet-based inter-
ventions for depression (Kolovos et al., 2018) found no statistically
significant differences between intervention participants and controls in
terms of costs or outcomes at 12months, and therefore a low prob-
ability that the intervention would be considered cost-effective.
1.2. What this paper adds
Mental health problems are expensive to treat, and can have costly
impacts on the health and social care sector and to wider society in
adulthood (Gustavsson et al., 2011). The overarching aim of this part of
the ICare programme is to increase availability of information about the
costs of treating people with internet-based interventions for policy-
makers, insurance companies and providers, and to add to the evidence
base for the cost-effectiveness of such interventions.
More specifically, our objectives are to use data from the clinical
trials to
• Identify the costs of treating people with the new technology-based
interventions compared to more traditional delivery methods;
• Undertake economic evaluations of the ICare internet-based inter-
ventions compared to care/treatment as usual (C/TAU; including
‘prevention as usual’) or other comparison groups within, and where
feasible across, the randomised controlled trials.
Rather than consider each clinical trial separately, this paper iden-
tifies the overarching approach to the economic evaluation of the ICare
interventions. Each of the seven trials is briefly described but fuller
details can be found in other articles in this Special Issue. The principles
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underlying economic evaluation are described first, including different
types of economic evaluation available (see also, Drummond et al.,
2015; Knapp, 1995). The subsequent section details the methods and
materials used within the ICare programme to apply these evaluative
principles to the ICare clinical studies. In the Discussion section, we
consider some of the challenges and limitations of undertaking eco-
nomic evaluation in this cross-national context.
2. Principles of economic evaluation
2.1. Economic costing
2.1.1. Perspective of analysis
When analysing the economic impact of social policies, a key con-
sideration concerns the perspective adopted for the analysis
(Drummond et al., 2015). Deciding on a perspective in this context
means deciding whose views need to be considered when it comes to
decision making about investment of public funds. A common distinc-
tion is between public sector costs, focussing on costs accruing to public
sector budgets, and societal or social costs, which include the per-
spective of everyone who bears a ‘cost’ as a result of illness, such as the
individual affected, their carers and families, and wider society such as
employers.
In the economic evaluation of ICare, we consider both a public-
sector perspective – focussing on health and social care costs – and a
societal perspective that incorporates productivity losses.
2.1.2. Types of economic costs
Economic costs fall into three categories: direct, indirect and human
costs. While direct costs are tangible, monetary costs, that can be de-
termined by observing immediate expenditure on health services, social
care and other services, indirect costs are opportunity costs that re-
present societal output forgone as a consequence of a disease or illness,
and measured in terms of lost productivity. Human costs are wider
impacts associated with premature mortality or pain and suffering.
Each is discussed in more detail below.
2.1.2.1. Direct costs. To determine direct costs, a unit cost for each
service is multiplied by the amount of service received by the
population under study. Thus, estimating unit costs of interventions
and other services and supports received by participants is a central
task. Beecham (2000, pp. 12–15) sets out the principles of unit costing,
reflecting economic theory:
• Unit costs should be inclusive, i.e. include resources needed to
provide all components of a service. This includes both fixed and
variable costs, or put differently: salary costs, on-costs and over-
heads, regardless of the budget or source providing these resources.
• Unit costs should be developed in such a way that they match ser-
vice use and allow for accurate costing of services received. For
example, an outpatient service may provide a variety of sessions,
ranging from brief visits with a nurse practitioner to one-to-one
therapy sessions with a consultant. These are very different in terms
of resource implications, and providing an overall unit cost for a
generic intervention with this service would not reflect actual re-
sources received by the client.
• Unit costs should be based on the principle of long-run marginal
opportunity costs. Economic costs include both ‘accounting costs’ –
costs that might, for example, be reflected in a public sector budget
– and ‘opportunity costs’ – the benefit forgone from not investing in
the next best alternative. In other words, not only the immediate
monetary expense needs to be considered, but also the value of the
benefit forgone by choosing one option over another ('opportunity
cost'). ‘Marginal cost’ refers to the cost of supporting an additional
patient in the service, whereas the focus on ‘long-run’ costs such as
capital investment in buildings highlights the need to consider the
implications of service expansion.
Beecham and Knapp (2001) highlight another important factor:
Estimating costs in a manner that recognises the variations in costs
between different service users, different facilities or different locations.
The implication for the economic evaluation of ICare interventions is
that country-specific unit costs need to be developed.
We can further identify two broad approaches to estimating unit
costs.
• In the ‘top-down’ approach, all relevant expenditure is added and
then divided by the corresponding unit of activity. This approach is
comparatively simple to apply, often using routinely-collected data,
and is most appropriate where an average cost – such as the average
cost per person receiving treatment through an eating disorder
service – is required. However, this approach does not allow analysis
of variation in costs, for example for patients requiring additional
support beyond a standard intervention or variation by patient
characteristics.
• In contrast, in the bottom-up approach all resources required to
provide a specific intervention or service are described and costed.
The monetary value of those resources is then linked to the service-
specific unit of activity. This approach tends to be more accurate
and versatile, as it can be linked to individuals, thus retaining
variability between patients and between sites.
These principles identified above guide our cost estimations for the
economic evaluation of ICare interventions. The heterogeneity of the
ICare interventions, the users and their needs, as well as the locations
means that the bottom-up approach is best suited to estimating inter-
vention costs and the costs associated with individual-level service use
data collected within the clinical trials.
2.1.2.2. Indirect costs: productivity losses. Productivity is based on the
theoretical model of the production function, where output is produced
by combining capital, labour and technology (inputs). Productivity is a
measure of output per unit of input and therefore productivity loss is
the value of lost output (Zhang et al., 2011).
Absenteeism is a measure of reduction in output due to days not
worked (work days lost). In the ICare trials absenteeism may be due to
acute illness or hospitalisation and medical appointments. Presenteeism
also reflects a reduction in productivity, but occurs while a person is at
work. It represents the difference in output in the presence of a con-
dition compared to output in the absence of the condition. Given the
complexity of many modern jobs, especially in non-manual, non-in-
dustrial settings where outputs cannot be easily defined nor counted,
and the complexity of an impairment resulting from a mental health
problem, assessments of presenteeism generally rely on self-report
measures rather than routinely-collected data (Schultz and Edington,
2007).
Productivity losses from absenteeism and presenteeism are often
valued using a human capital approach. In short, the human capital
method places a value on lost output by calculating the sum of dis-
counted expected future income. The theoretical justification for this
approach is that the market wage is equal to the marginal product of
labour in a competitive market (Zhang et al., 2011), and therefore re-
presents the opportunity cost of lost output to society.
One criticism of the human capital approach is that it disregards
unpaid work, such as housework and caregiving, and leisure activities.
To determine a ‘shadow price’ for these activities, the opportunity cost
of lost time spent on unpaid work needs to be developed. Several op-
tions have been proposed for values based on opportunity costs (for an
accessible summary, see Francis and McDaid, 2009): market wage
forgone based on an individual's likely earnings; average wage; or
minimum wage. An alternative is to use a ‘replacement cost’. This ap-
proach values the (lost) output produced as the cost of purchasing an
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equivalent service on the market such as the cost of child care or the
cost of hiring a nurse or caregiver. Valuing leisure time presents a
number of additional challenges, usually requiring the use of proxy
measures to achieve a valuation. For example, the UK Department for
Transport has calculated an opportunity cost for leisure time based on
travel time avoided (Department for Transport, 2009).
2.2. Economic evaluation
2.2.1. Theoretical background: production of welfare approach
Underpinning each evaluative mode must be a clear understanding
of how costs and outcomes can be linked. The Production of Welfare
(PoW) approach provides this framework (Knapp, 2001). Based in
traditional micro-economics, its predecessor is the classic theory of
production, or the assumption that inputs (labour and capital) are
combined to produce outputs (cars, for example). In a person-to-person
service such as health care, these relationships are more complex as
people form the basis of both inputs and outputs so their attributes have
a large effect on the quantity and quality of outcomes.
The four main PoW elements are inter-related. Resource inputs are
the labour and capital used to create a service, which can be sum-
marised in monetary terms as cost. Service outputs (intermediate out-
comes) are the levels or volume of services produced or used. Non-re-
source inputs are less easy to measure but can help explain outcome
differences. They include the social features of the care environment
and the characteristics, experiences, personalities and attitudes of the
main actors (staff and users) in the system. Non-resource inputs,
therefore, include potential mediators and moderators of outcomes (see
Knapp, 2001). In health care, the aim is not to produce services but to
produce better health and welfare; the fourth PoW component is final
outcomes – changes in people's health and welfare.
Thus, the Production of Welfare framework can help structure re-
search, explain, justify and clarify reasons why data are collected and
analyses undertaken, and can help interpret results sensibly. Such fra-
meworks are particularly important when undertaking analyses on a
new topic. The model suggests a causal link between resources inputs
(summarised by costs) and final outcomes, mediated by different
combinations of non-resources inputs and service outputs. By clearly
locating measures used to assess ICare interventions within the PoW
model, the specific links – and their strength – between outcomes, costs
and savings to the health care system will be identified.
2.2.2. Types of economic evaluation
According to Drummond et al. (2015), economic evaluation re-
quires
• A comprehensive assessment of all costs and savings from the in-
tervention;
• Assessment of outcomes;
• A relevant metric to allow comparison of one or more alternatives.
Where one or several of these elements are missing, a partial eco-
nomic evaluation can be provided. A cost of illness study, for example is
a partial economic evaluation as only cost data are available. So too is
an analysis of efficacy, as this assesses outcomes using a comparative
design, but does not incorporate any cost data.
The following are examples of full economic evaluation types that
will be applied in the ICare programme:
1) Cost-consequence analyses set out the costs to the stakeholders
alongside outcomes achieved. Such analyses are useful when an
intervention has several desirable outcomes; perhaps the primary
clinical outcome but also factors such as quality of life or satisfaction
with the intervention.
2) Cost-effectiveness analyses (CEA) combine costs with a clinical out-
come measure or other ‘natural unit’ and compare the cost-per-
outcome gained for each option. For example, if two options are of
equal cost, which provides greater benefit to the patient or popu-
lation?
3) Often considered a special case of CEA, the outcome used in cost-
Box 1
Trials and participants.
The ICare trials are described in more detail in other papers in this issue and only brief details are given here.
Study 1 aims to bridge waiting time for people waiting for outpatient treatment in Germany and the UK. Two hundred and seventy-five
women will be randomly allocated to the ‘everyBody Plus’ intervention or to a waiting list control group.
Study 2 uses a tailored prevention intervention to help women with negative body image and symptoms of disordered eating. It is a
non-randomised parallel intervention study, with 4,160 participants from the general population in German-speaking countries directed to
one of five variants of the ‘everyBody’ intervention.
Study 3 evaluates an unguided web-based programme (CORE) to promote resilience and coping skills, decrease symptoms of depression
and anxiety, and increase overall wellbeing in young people. This RCT will compare CORE with care as usual among a minimum of 454
university students in Spain, Germany and Switzerland.
Study 4 evaluates a prevention programme for common mental health disorders across 954 participants with sub-clinical symptoms of
depression or anxiety per group, recruited from Germany, Switzerland, Spain, and the Netherlands. The RCT will compare two active
treatments (guided and unguided ICare Prevent) and treatment as usual (TAU). Participants allocated to the TAU arm will receive the
intervention after 12months.
Study 5 aims to evaluate an intervention to promote a healthy lifestyle and to reduce problematic eating behaviour, eating disorder and
obesity risk among students aged 14 to 19 years old. An RCT, clustered by school, will recruit at least 430 young people to participate in the
intervention programmes (Weight Management and Healthy Habits) or a no-intervention control group, from school settings in Austria and
Spain. Participants allocated to the control group arm will receive the intervention after 12months.
Study 6 evaluates the web-based PLUS trans-diagnostic mental health problem prevention programme using a parallel group RCT
across universities in the UK, the Republic of Ireland, Austria, and Germany. Students (N=1,100) at high risk of developing common
mental disorders will be randomly allocated to either PLUS or an intervention providing practical support for issues commonly experienced
at University.
Study 7 is an RCT evaluating three forms of the We Can web-based intervention for carers of individuals with anorexia nervosa; with
clinician email support (We Can-Ind), with moderated carer chatroom support (We Can-Chat), and with online forum only (We Can-
Forum). The study will recruit 303 carers (and, where possible, the care recipient) through specialist eating disorder services and carer
support services in the UK and Germany.
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utility analysis (CUA) is health-related quality of life, which is valued
in line with population preferences (utility). Commonly a cost per
quality adjusted life year (QALY) gained is calculated. QALYs are a
highly conflated measure and not fully relevant for all conditions,
but their widespread use means comparisons can be made across
conditions.
These approaches should be distinguished from (and are often
confused with) cost-benefit analysis, which values both outcomes and
costs in the same metric, usually in monetary terms.
3. Materials and methods
3.1. Participants and interventions
The participants for the ICare economic evaluations are those re-
cruited to the individual ICare clinical trials. Box 1 provides a brief
overview of the interventions, study design, and target recruitment
numbers for the intervention and control groups and more information
can be found in other papers in this Special Issue. Participants providing
data on outcome measures, demographics and service use at baseline
will be included in the main analysis. Sensitivity analysis will be per-
formed using complete-case analysis.
3.2. Assessment and data management
Data management and monitoring will be provided by the
Westfälische Wilhelms-Universität Münster, Institute of Biostatistics
and Clinical Research. Support is provided for the whole consortium in
order to maintain comparable high quality in the conduct of the ICare
research projects in trial planning, data management, online mon-
itoring, and analysis.
Within the ICare project a harmonised data management plan is
implemented to provide high quality data with respect to accuracy,
composition and organisation, completeness, transparency of processes,
and timeliness. During the active phase of the trial data (i) complete-
ness, (ii) timeliness and (iii) internal validity will be monitored. Internal
validity will be checked by plausibility rules. Data will be collected on
the Minddistrict platform. After export from the platform data will be
processed in a unified manner for all ICare studies, using programming
scripts.
Data security and confidentiality will be ensured; all relevant EU
legislation and international guidelines on privacy will be observed and
respected. Regarding regulation at international level, starting from the
OECD guidelines including the “Guidelines on the protection of privacy
and trans-border flow of personal data” (1981) and “Guidelines for the
security of information systems” (1991/92), the ICare consortium in
particular acknowledges heterogeneity in international data protection
jurisdiction.
3.3. Measures for economic evaluation
For ICare economic evaluations there are three data collection tasks
over and above data associated with characteristics of participants or
their needs and outcomes. These relate to the way resources are used to
deliver the ICare interventions, and to the services and supports study
participants received from other parts of the health and social care
system. Information to calculate productivity losses also needs to be
collected. There is an addition layer of work around harmonizing the
service use data to read across different countries' health care systems
and service arrays.
3.3.1. Service use
A specially adapted version of the Client Service Receipt Inventory
(CSRI; Beecham and Knapp, 2001) was developed to record use of
services and medication at baseline and at the six-month and 12-month
follow-up, covering a retrospective six-month period. Participants will
be asked to provide the number of contacts with primary care, hospital
services, specialist mental health services, social work and other com-
munity services.
From the original English version, the CSRI was translated for each
country and language (with minor adjustments to wording to reflect the
clinical focus of each individual trial) with the help of the local ICare
research teams. The translation focussed not on a word for word
translation, but rather on extracting equivalent information that ap-
propriately reflects each country's health and social care system, and
that uses language appropriate to the country context. In addition, for
each country, questions and response options were structured so that
relevant unit costs can be estimated and applied.
3.3.2. Productivity losses
A measure of productivity loss and impairment of other activities
was incorporated into the CSRI, based on an adaptation of the Work
Productivity and Activity Impairment Questionnaire – General Health
(WPAI-GH; Reilly et al., 1993). This questionnaire was translated into
the target languages with small modifications in the wording to reflect
the clinical focus of each trial.
3.3.3. Outcome measures
Full details of primary outcome measures can be found in the pro-
tocol paper of each individual clinical study. In addition to the primary
outcome, there are three outcome measures used in multiple trials that,
where appropriate, will be used for cost-effectiveness analysis across
trials.
• Severity of depression will be assessed using the Patient Health
Questionnaire (PHQ-9, Kroenke et al., 2001). This self-report mea-
sure includes nine items describing depressive symptoms. PHQ-9
will only be assessed in adult populations.
• Severity of anxiety will be assessed using the Generalised Anxiety
Disorder scale (GAD-7, Spitzer et al., 2006). It consists of seven
items relating to symptoms of generalised anxiety. GAD-7 will only
be assessed in adult populations.
• The Eating Disorder Examination – Questionnaire (EDE-Q, Fairburn
and Beglin, 1994) is a self-report version of the well-established
interview version of the EDE (Fairburn and Cooper, 1993), con-
sisting of a series of questions regarding eating disordered beha-
viours, and concerns over shape and weight. EDE-Q will only be
collected for interventions targeting disordered eating behaviours.
In addition to these outcome measures, we will explore the potential
of using measures of quality of life (QoL) to conduct cost-utility ana-
lysis. Two QoL measures are used as part of different ICare trials:
• The WHOQOL-BREF (The Whoqol Group, 1998) is a self-report
measure that assesses quality of life using 26 items on the domains
of physical health, psychological health, social relationships, and
environment.
• The Assessment of Quality of Life-8D (AQOL-8D, Richardson et al.,
2014) is a 35 item instrument for the assessment of quality of life
and comprises eight dimensions – independent living, pain, senses,
relationships, mental health, happiness, coping, and self-worth.
• For trials employing the AQOL-8D, we will calculate quality-ad-
justed life years using previously developed algorithms (Dakin,
2013).
3.4. Unit costs
There is some debate in the literature about the scope of data to
collect around the costs of internet-based interventions. McNamee et al.
(2016) discuss this at some length reminding the reader that most costs
are incurred at the development stage; their review found costs ranging
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from £20,000 to £500,000 (p. 856) and that maintenance costs (such as
hosting costs) can be very low. Other costs specific to internet inter-
ventions may be for regular updating to ensure the intervention ‘re-
mains the same’ (e.g. providing up-to-date information, or for software
development), or where evolution over time occurs and is desirable
and/or planned (McNamee et al., 2016). In the short-term evaluations
that form part of the ICare programme, we exclude these ‘sunk costs’
and include only costs that will have to be incurred should the inter-
vention be used again (see also, Donker et al., 2015).
The main recurring resource for ICare interventions are therapists
and moderators providing moderated forums, weekly chats and 1-to-1
guidance through the Minddistrict online platform. Information on
salaries, oncosts and overheads will be collected from intervention
providers, and a cost of staff calculated in line with the theoretical
approach outlined above (Beecham, 2000).
A Service Information Schedule (SIS) will be developed to collect
information on salaries, on-costs and any relevant overheads associated
with the therapists and moderators. This will allow us to calculate the
cost associated with staff time required to provide the interventions.
The cost of general resources (moderated forums and chats) will be
divided by the number of registered participants to provide a per-par-
ticipant cost. In addition, moderators will be asked to provide in-
formation on time spent per typical week moderating forums and
moderating weekly chats to capture resources available to all inter-
vention participants, and time spent on providing individual feedback
and sending individual reminders designed to improve adherence. The
cost associated with individual feedback will be calculated for each
participant to capture individual-level variations in the intensity of
support. To balance the need for accurate data with the need to reduce
the burden on providers of information, this will be achieved by ob-
taining data on a) the average time it takes therapists to provide
feedback and b) identifying which individual participants required time
input that is higher than the average.
The second set of tasks related to unit cost estimations is to place a
monetary value on the resources (services and supports) used by trial
participants. Informed by the principles set out above, unit costs will be
estimated for each trial drawing on national compilations (see for ex-
ample Curtis, 2016; Department of Health, 2016; Hakkaart-van Roijen
et al., 2016; Krauth et al., 2005; Bock et al., 2015), other local or
European data, and other research.
3.5. Analyses
3.5.1. Service use and costs
Service use will be described at each time point, by intervention
group, showing the number and proportion of participants reporting
use of any given service. The unit cost for each service or support will
be multiplied by the amount of service use each person has recorded on
the CSRI for each time period. To ensure that costs are equivalent across
countries, they will be expressed in Euro converted to a constant unit
using each countries consumer price index and purchasing power pa-
rities (PPP; http://www.oecd.org/std/prices-ppp/) for total consump-
tion, i.e. gross domestic product (GDP; Gustavsson et al., 2011). Means
and standard deviations for costs by category (e.g. primary care, spe-
cialist mental health care, total costs) will be presented by treatment
group for each time point.
Productivity losses will be calculated using a human capital ap-
proach. Loss from absence from paid employment (absenteeism) will be
calculated as wages forgone, either based on self-reported wage or
median earnings for a participant's occupation (where available). Losses
associated with reduced productivity while at work (presenteeism) will
be estimated by multiplying the daily wage (derived as above) by the
average percentage reduction in productivity due to depression, sadness
or mental illness (15.3%, Goetzel et al., 2004). Opportunity costs from
the impact on daily routines will be valued using the relevant minimum
wage or median wage for the lowest skilled group in the labour market
where no minimum wage is in place. The impact on leisure time will be
valued by first calculating the average number of hours of leisure time
for all participants based on time use surveys for their respective
country or – where unavailable – a country with a similar labour market
structure. This will then be valued at the rate for the value of leisure
time, such as the value of travel time avoided (Department for
Transport, 2009). Where such a value is unavailable, the rate will be
estimated as a proportion of the minimum wage corresponding to the
average of countries where this information is available.
3.5.2. Cost-consequence and cost-effectiveness analyses
Cost-consequence analysis contrasts differential costs with differ-
ential outcomes, adjusted for salient socio-economic and baseline
characteristics. Given that cost data are often skewed, with many par-
ticipants incurring low or zero costs and a few incurring very high costs,
appropriate statistical methods will be chosen after assessing their
distribution. Common approaches include non-parametric bootstraps
(Efron and Tibshirani, 1993), or Generalised Linear Models (GLMs)
with an appropriate distribution and link function, such as a gamma
distribution with a log link (e.g. Kilian et al., 2002).
Cost-effectiveness analysis will be conducted for clinical outcome
variables and – where available – a measure of QoL (cost-utility ana-
lysis) for each trial. Results will be presented as incremental cost-ef-
fectiveness ratios (ICERs) with their corresponding 95% confidence
intervals and cost-effectiveness acceptability curves (CEACs). All ana-
lyses will adjust for relevant participant characteristics and baseline
scores. The ICER represents the additional cost for an incremental im-









However, summarizing this information in one figure is proble-
matic, as a positive ratio can represent both higher costs and better
outcomes in the experimental group, and lower costs and less favour-
able outcomes (compared to the control group). Moreover, a negative
ratio can indicate higher costs coupled with worse outcomes (TAU
dominates the intervention) as well as lower costs and better outcomes
(intervention dominates TAU). Scatter plots of at least 1000 bootstrap
replications of the ICER will therefore be presented to aid the inter-
pretation of the ICER and the assessment of uncertainty surrounding it.
CEACs address the problems associated with the ICER by offering a
way to examine the probability of the intervention being cost effective,
given various values for society's willingness to pay (WTP) for a unit
improvement in outcome. CEACs are often based on the concept of net
monetary benefit (NMB). Net benefit variables are calculated for a
range of possible values for WTP for all outcome variables by multi-
plying WTP by the outcome, and subtracting costs (Fenwick and Byford,
2005; Glick et al., 2007; O'Brien and Briggs, 2002). The difference in
NMB between treatment groups for each value of WTP is estimated
using a net benefit regression framework.
Where participant characteristics are associated with clinical out-
comes and costs, respectively, or where the goal is to implement sub-
group analysis, the assessment of cost-effectiveness and cost-utility of
the ICare interventions will use Seemingly Unrelated Regression
(Zellner, 1962). Here, separate regression models are fitted for a) costs
at follow-up and b) each of the outcome measures considered in the
economic evaluation as the dependent variable (Hoch et al., 2002). The
goal is again to estimate group differences.
Within these analytical frameworks it is possible to control for
baseline scores, baseline costs and confounding variables (Glick et al.,
2007; Hoch et al., 2002). Bootstrapping will be used to obtain multiple
estimates for the group difference, allowing a probabilistic interpreta-
tion of results: The percentage of estimates of the group difference
greater than one – indicating better results for the experimental group –
is plotted for each value of WTP, resulting in the CEAC (Byford et al.,
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All models will take into account clustering within countries and –
where analysis across several trials is performed – within trials as ap-
propriate. Analyses will be shown for a) public sector costs only and b)
costs including public sector costs and productivity losses. Missing data
will be addressed using multiple imputation (see Little and Rubin, 2002
for handling bootstrap in the context of multiple imputation). A blinded
data review will inform the imputation strategy and the selection of
multivariable models. To assess the effect of missing data, the analysis
will be performed on the imputed data, and on complete cases.
4. Discussion and conclusion
This paper describes the activities to be undertaken in the economic
evaluation of the interventions forming the ICare programme. The
economic evaluations form an overarching “work-package” within the
EU grant funding which covers cost and cost-effectiveness studies
across seven clinical trials recruiting from six countries. There are be-
tween 250 and 4000 participants in each trial and while some pro-
grammes are targeted on school children or university students, others
provide interventions for adults who have, or are at risk of developing,
(mental) health problems.
Having a strong theoretical underpinning is key to the success of any
research endeavour. The Production of Welfare (PoW) provides a clear
framework for how costs and outcomes can be linked, derived from the
classic theory of production (Knapp, 2001). Clearly delineating the
relationships between resources inputs, non-resource inputs, inter-
mediate outputs, and final outcomes helps disentangle the complexity
of the relationships and can help interpret results sensibly. By locating
the evaluative elements of the ICare interventions within that frame-
work, the specific links between outcomes, costs and savings to the
health care system will be identified.
There are a number of challenges. For example, each of the trials
occur in at least two countries so operate across health care cultures
where differences in ostensibly similar services, or combination of
services, have to be acknowledged. Cross-national studies also require
attention to be paid to the financing system and the monetary valuation
of these services and supports. Complexity arises here not only because
the similar professionals may undertake a different role and be sup-
ported by their employing organisation in a different way, but also
because the relative value of goods is different in each country. The aim
is to ensure equivalence.
Our tasks include the development of data collection schedules,
estimation of unit costs and productivity losses, analysis of service use
information and costs, as well as the joint analysis of costs and out-
comes. There are few existing research studies to inform or compare the
findings. Around half of the economic evaluations that have been re-
viewed were considered to be good quality, but often the perspective is
narrow. The evidence tends to favour guided internet interventions as
being more cost-effective than the selected comparator but the evidence
base is much weaker when specific conditions are considered. The ex-
isting published papers consider a range of health problems but many of
the interventions studied are based on just one treatment (ICBT). The
ICare programme also includes interventions for people with eating
disorders (including carers) and obesity, common mental health dis-
orders (depression, anxiety, harmful or hazardous alcohol use and co-
morbid problems), and adjustment disorder. The interventions also
include mental health promotion and prevention programmes, as well
as interventions for at risk populations. While this is a strength of the
ICare programme and can broaden the reach of internet intervention, it
brings challenges to the evaluation by reducing comparability between
studies.
Research evidence tends to support use of internet-based interven-
tion of the grounds of greater effectiveness but is less well supported in
terms of the evidence on costs and cost-effectiveness. Not only is the
body of evidence on cost-effectiveness much smaller but neither does it
cover the breadth of health conditions and interventions proposed by
ICare. However, information on costs and cost-effectiveness are an
important consideration for policy-makers and providers as they make
decisions about how to spend their limited resources. This paper
identifies the theory-based approach to economic evaluation that will
underpin the analyses to produce major findings around the cost-ef-
fectiveness of internet interventions for treatment, prevention and
health promotion.
Competing interests
The authors declare that they have no competing interests.
Funding
This project has received funding from the European Union's
Horizon 2020 research and innovation programme under grant agree-
ment No 634757.
Author contributions
JB designed the economic evaluation in the first place. EMB con-
tributed significantly to the design of the economic evaluation. All co-
authors supported the adaptation of the CSRI for use in individual trials
and countries. JB and EMB co-wrote the manuscript. JB, EMB, DG, IB,
CB, DE, MZ, KW, RP and CJ contributed revisions to the manuscript. All
authors read and approved the final manuscript.
Ethical issues
There will be no additional ethical issues linked to the economic
evaluation of ICare interventions over and above those identified for
the individual RCTs. Primary data will be collected within these trials
or through the platform and will be anonymised before sent to the
economics team.
Acknowledgements
The activities described form part of the European research project:
Integrating Technology into Mental Health Care Delivery in Europe
(ICare, N° 634757, www.icare-online.eu). The main objective of the
ICare project is to develop an integrated model of health promotion and
risk prevention as well as detection of the most prevalent disorders in
Europe (i.e., depression, anxiety, adjustment disorder, eating disorders,
and substance abuse), guiding people and professionals in the selection
and application of online evidence-based interventions. US receives
salary support from the National Institute for Health Research (NIHR)
Biomedical Research Centre for Mental Health, South London and
Maudsley NHS Foundation Trust and Institute of Psychiatry,
Psychology and Neuroscience, King's College London. She is also sup-
ported by an NIHR Senior Investigator Award. The views expressed in
this publication are those of the authors and not necessarily those of the
National Health Service, the NIHR or the UK Department of Health.
References
Arnberg, F.K., Linton, S.J., Hultcrantz, M., Heintz, E., Jonsson, U., 2014. Internet-deliv-
ered psychological treatments for mood and anxiety disorders: a systematic review of
their efficacy, safety, and cost-effectiveness. PLoS ONE 9 (5), e98118. [Electronic
Resource]. https://doi.org/10.1371/journal.pone.0098118.
Beecham, J., 2000. Unit Costs - Not Exactly Child’s Play. A Guide to Estimating Unit Costs
for Children’s Social Care. Department of Health, Dartington Social Research Unit &
PSSRU, Dartington Retrieved from. http://www.pssru.ac.uk/pdf/B062.pdf.
Beecham, Jennifer, Knapp, Martin, 2001. Costing psychiatric interventions. In:
Thornicroft, G. (Ed.), Measuring Mental Health Needs, Second Ed. Royal College of
Psychiatrists, London, pp. 200–224.
Bock, J.O., Brettschneider, C., Seidl, H., Bowles, D., Holle, R., Greiner, W., König, H.H.,
2015. Ermittlung Standardisierter Bewertungssätze Aus Gesellschaftlicher
J. Beecham et al. Internet Interventions xxx (xxxx) xxx–xxx
7
Perspektive Für Die Gesundheitsökonomische Evaluation. Gesundheitswesen 77 (1),
53–61. http://dx.doi.org/10.1055/s-0034-1374621.
Byford, S., Knapp, M., Greenshields, J., Ukoumunne, O.C., Jones, V., Thompson, S., Tyrer,
P., Schmidt, U., Davidson, K., 2003. Cost-effectiveness of brief cognitive behaviour
therapy versus treatment as usual in recurrent deliberate self-harm: a decision-
making approach. Psychol. Med. 33 (6), 977–986.
Curtis, L., 2016. Unit Costs of Health and Social Care 2016. Personal Social Services
Research Unit, University of Kent, Canterbury.
Dakin, Helen, 2013. Review of studies mapping from quality of life or clinical measures to
EQ-5D: an online database. Health Qual. Life Outcomes 11 (1), 151. http://dx.doi.
org/10.1186/1477-7525-11-151.
Department for Transport, 2009. Values of Time and Operating Costs. TAG Unit 3.5.6. In:
Transport Analysis Guidance. Department for Transport, London.
Department of Health, 2016. NHS reference costs 2015–16. Department of Health,
London.
Donker, T., Blankers, M., Hedman, E., Ljótsson, B., Petrie, K., Christensen, H., 2015.
Economic evaluations of internet interventions for mental health: a systematic re-
view. Psychol. Med. 45 (16), 3357–3376. http://dx.doi.org/10.1017/
S0033291715001427.
Drummond, M.F., Jefferson, T.O., Gerard, K., Adams, M.E., McCall, N.T., Gray, D.T., Orza,
M.J., et al., 1996. Guidelines for authors and peer reviewers of economic submissions
to the BMJ. The BMJ economic evaluation working party. BMJ (Clin. Res. Ed.) 313
(7052), 275–283. http://dx.doi.org/10.1136/bmj.313.7052.275.
Drummond, M., Stoddard, G.L., Torrance, G.W., 2015. Methods for the Economic
Evaluation of Health Care Programmes, 4th ed. University Press, Oxford.
Efron, B., Tibshirani, R.J., 1993. An introduction to the bootstrap. In: Monographs on
Statistics and Applied Probability. vol. 57 Chapman and Hall, New York. http://dx.
doi.org/10.1111/1467-9639.00050.
European Commission, 2012. eHealth Action Plan 2012–2020: Innovative Healthcare for
the 21st Century. http://ec.europa.eu/digital-agenda/en/news/ehealth-action-plan-
2012-2020-innovative-healthcare-21st-century Retrieved 26/10/2017.
Fairburn, Christopher G., Beglin, Sarah J., 1994. Assessment of eating disorders: inter-
view or self-report questionnaire? Int. J. Eat. Disord. 16 (4), 363–370. http://dx.doi.
org/10.1002/1098-108X(199412)16:4<363::AID-EAT2260160405>3.0.CO;2-#.
Fairburn, C., Cooper, Z., 1993. The Eating Disorder Examination. In: Nature, Assessment
and Treatment, pp. 317–360.
Fenwick, E., Byford, S., 2005. A guide to cost-effectiveness acceptability curves. Br. J.
Psychiatry 187, 106–108. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=
Retrieve&db=PubMed&dopt=Citation&list_uids=16055820.
Francis, J., McDaid, D., 2009. SCIE’s work on economics and the importance of informal
care. In: Curtis, L. (Ed.), Unit costs of health and social care 2009. Personal Social
Services Research Unit, University of Kent, Canterbury, pp. 27–33. Retrieved from.
http://eprints.lse.ac.uk/32770/.
Glick, H.A., Doshi, J.A., Sonnad, S.S., Polsky, D., 2007. Economic Evaluation in Clinical
Trials. Oxford University Press Catalogue.
Goetzel, Ron Z., Long, Stacey R., Ozminkowski, Ronald J., Hawkins, Kevin, Wang,
Shaohung, Lynch, Wendy, 2004. Health, absence, disability, and presenteeism cost
estimates of certain physical and mental health conditions affecting U.S. employers.
J. Occup. Environ. Med. 46 (4), 398–412. http://dx.doi.org/10.1097/01.jom.
0000121151.40413.bd.
Griffiths, Frances, Lindenmeyer, Antje, Powell, John, Lowe, Pam, Thorogood, Margaret,
2006. Why are health care interventions delivered over the internet? A systematic
review of the published literature. J. Med. Internet Res. http://dx.doi.org/10.2196/
jmir.8.2.e10.
Gustavsson, Anders, Svensson, Mikael, Jacobi, Frank, Allgulander, Christer, Alonso, Jordi,
Beghi, Ettore, Dodel, Richard, et al., 2011. Cost of disorders of the brain in Europe
2010. Eur. Neuropsychopharmacol. 21 (10), 718–779. http://dx.doi.org/10.1016/j.
euroneuro.2011.08.008.
Hakkaart-van Roijen, L., van der Linden, N., Bouwmans, C., Kanters, T., Swan Tan, S.,
2016. Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen
voor economische evaluaties in de gezondheidszorg. Zorginstituut Nederland 1–73.
Retrieved from. www.zorginstituutnederland.nl/publicaties/publicatie/2016/02/
29/richtlijn-voor-het-uitvoeren-van-economische-evaluaties-in-de-gezondheidszorg.
Hedman, Erik, Andersson, Erik, Ljótsson, Brjánn, Andersson, Gerhard, Rück, Christian,
Lindefors, Nils, 2011. Cost-effectiveness of internet-based cognitive behavior therapy
vs. cognitive behavioral group therapy for social anxiety disorder: results from a
randomized controlled trial. Behav. Res. Ther. 49 (11), 729–736. http://dx.doi.org/
10.1016/j.brat.2011.07.009.
Hedman, Erik, Ljótsson, Brjánn, Lindefors, Nils, 2012. Cognitive behavior therapy via the
internet: a systematic review of applications, clinical efficacy and cost–effectiveness.
Expert Rev. Pharmacoecon. Outcomes Res. 12 (6), 745–764. http://dx.doi.org/10.
1586/erp.12.67.
Hoch, J.S., Briggs, A.H., Willan, A.R., 2002. Something old, something new, something
borrowed, something blue: a framework for the marriage of health econometrics and
cost-effectiveness analysis. Health Econ. 11 (5), 415–430.
Hollinghurst, Sandra, Peters, Tim J., Kaur, Surinder, Wiles, Nicola, Lewis, Glyn, Kessler,
David, 2010. Cost-effectiveness of therapist-delivered online cognitive-behavioural
therapy for depression: randomised controlled trial. Br. J. Psychiatry 197 (4),
297–304. http://dx.doi.org/10.1192/bjp.bp.109.073080.
Kelders, Saskia M., Kok, Robin N., Ossebaard, Hans C., Van Gemert-Pijnen, Julia E.W.C.,
2012. Persuasive system design does matter: a systematic review of adherence to
web-based interventions. J. Med. Internet Res. http://dx.doi.org/10.2196/jmir.2104.
Kilian, Reinhold, Matschinger, Herbert, Loeffler, W., Roick, Christiane, Angermeyer,
Matthias C., 2002. A comparison of methods to handle skew distributed cost variables
in the analysis of the resource consumption in schizophrenia treatment. J. Ment.
Health Policy Econ. 5 (1), 21–31.
Knapp, M., 2001. Economic evaluation of mental health care. In: Contemporary
Psychiatry. Springer Berlin Heidelberg, Berlin, Heidelberg, pp. 259–277. http://dx.
doi.org/10.1007/978-3-642-59519-6_16.
The Economic Evaluation of Mental Health Care. In: Knapp, M. (Ed.), Ashgate Publishing,
Farnham UK.
Kolovos, S., van Dongen, J.M., Riper, H., Buntrock, C., Cuijpers, P., ... Ebert,
D.D.Bosmans, 2018. Cost effectiveness of guided Internet-based interventions for
depression in comparison with control conditions: an individual-participant data
meta-analysis. Depress. Anxiety 209–219. http://dx.doi.org/10.1002/da.22714.
(November 2017).
Krauth, Christian, Hessel, F., Hansmeier, T., Wasem, J., Seitz, R., Schweikert, B., 2005.
Empirische Bewertungssätze in Der Gesundheitsökonomischen Evaluation - Ein
Vorschlag Der AG Methoden Der Gesundheitsökonomischen Evaluation (AG MEG).
Gesundheitswesen 67 (10), 736–746. http://dx.doi.org/10.1055/s-2005-858698.
Kroenke, K., Spitzer, R.L., Williams, J.B., 2001. The PHQ-9: validity of a brief depression
severity measure. J. Gen. Intern. Med. 16, 606–613.
Little, R.J., Rubin, D.B., 2002. Statistical Analysis With Missing Data. Wiley-Interscience,
Hoboken, N.
McConnon, Áine, Kirk, Sara F.L., Cockroft, Jennie E., Harvey, Emma L., Greenwood,
Darren C., Thomas, James D., Ransley, Joan K., Bojke, Laura, 2007. The internet for
weight control in an obese sample: results of a randomised controlled trial. BMC
Health Serv. Res. 7 (1), 206. http://dx.doi.org/10.1186/1472-6963-7-206.
McNamee, Paul, Murray, Elizabeth, Kelly, Michael P., Bojke, Laura, Chilcott, Jim, Fischer,
Alastair, West, Robert, Yardley, Lucy, 2016. Designing and undertaking a health
economics study of digital health interventions. Am. J. Prev. Med. 51 (5), 852–860.
http://dx.doi.org/10.1016/j.amepre.2016.05.007.
Mihalopoulos, C., Kiropoulos, L., Shih, S.T., Gunn, J., Blashki, G., Meadows, G., 2005.
Exploratory economic analyses of two primary care mental health projects: im-
plications for sustainability. Med. J. Aust. 183 (10 Suppl), S73–6 (doi:mih10602_fm
[pii).
O'Brien, B.J., Briggs, A.H., 2002. Analysis of uncertainty in health care cost-effectiveness
studies: an introduction to statistical issues and methods. Stat. Methods Med. Res. 11
(6), 455–468.
OECD/EU, 2016. Health at a Glance: Europe 2016: State of Health in the EU Cycle. OECD
Publishing, Paris.
Paganini, S., Teigelkötter, W., Buntrock, C., Baumeister, H., 2018. Economic evaluations
of internet- and mobile-based interventions for the treatment and prevention of de-
pression: a systematic review. J. Affect. Disord. 225, 733–755. http://dx.doi.org/10.
1016/j.jad.2017.07.018.
Palmqvist, Björn, Carlbring, Per, Andersson, Gerhard, 2007. Internet-delivered treatments
with or without therapist input: does the therapist factor have implications for effi-
cacy and cost? Expert Rev. Pharmacoecon. Outcomes Res. 7 (3), 291–297. http://dx.
doi.org/10.1586/14737167.7.3.291.
Reilly, M.C., Zbrozek, A.S., Dukes, E.M., 1993. The validity and reproducibility of a work
productivity and activity impairment instrument. PharmacoEconomics 4 (5),
353–365. http://dx.doi.org/10.2165/00019053-199304050-00006.
Richardson, Jeff, Iezzi, Angelo, Khan, Munir A., Maxwell, Aimee, 2014. Validity and re-
liability of the assessment of quality of life (AQoL)-8D multi-attribute utility instru-
ment. The Patient 7 (1), 85–96. http://dx.doi.org/10.1007/s40271-013-0036-x.
Schultz, A.B., Edington, D.W., 2007. Employee health and presenteeism: a systematic
review. J. Occup. Rehabil. 17 (3), 547–579.
Spitzer, Robert L., Kroenke, Kurt, Williams, Janet B.W., Löwe, Bernd, 2006. A brief
measure for assessing generalized anxiety disorder: the GAD-7. Arch. Intern. Med.
166, 1092–1097. http://dx.doi.org/10.1001/archinte.166.10.1092.
Tate, Deborah F., Finkelstein, Eric A., Khavjou, Olga, Gustafson, Alison, 2009. Cost ef-
fectiveness of internet interventions: review and recommendations. Ann. Behav. Med.
38 (1), 40–45. http://dx.doi.org/10.1007/s12160-009-9131-6.
The Whoqol Group, 1998. Development of the world health organization WHOQOL-BREF
quality of life assessment. The WHOQOL group. Psychol. Med. 28, 551–558.
Zellner, A., 1962. An efficient method of estimating seemingly unrelated regression
equations and tests for aggregation bias. J. Am. Stat. Assoc. 57, 348–368.
Zhang, W., Bansback, N., Anis, A.H., 2011. Measuring and valuing productivity loss due
to poor health: a critical review. Soc. Sci. Med. 72 (2), 185–192. http://dx.doi.org/
10.1016/j.socscimed.2010.10.026.
J. Beecham et al. Internet Interventions xxx (xxxx) xxx–xxx
8
